Track the 바이오니아 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 바이오니아 has recorded 61 insider filings. The latest transaction was reported on 4 February 2026 (Other). Among the most active insiders: 이중열. Every trade is free.
61
Insider Decl.
n/a
Thresholds
n/a
20 ops.
Buy Volume
n/a
1 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
BioNia es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones biofarmacéuticas.
